ONDANSETRON (GR38032F) PLUS DEXAMETHASONE - EFFECTIVE ANTIEMETIC PROPHYLAXIS FOR PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY

被引：49
|
作者：
SMITH, DB
NEWLANDS, ES
SPRUYT, OW
BEGENT, RHJ
RUSTIN, GJS
MELLOR, B
BAGSHAWE, KD
机构：
[1] Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London
来源：
BRITISH JOURNAL OF CANCER | 1990年 / 61卷 / 02期
关键词：
D O I：
10.1038/bjc.1990.62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [41] Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice
    Ithimakin, Suthinee
    Runglodvatana, Kanakorn
    Nimmannit, Akarin
    Akewanlop, Charuwan
    Srimuninnimit, Vichien
    Keerativitayanan, Narong
    Soparattanapaisarn, Nopadol
    Laocharoenkeat, Apirom
    SUPPORTIVE CARE IN CANCER, 2012, 20 (04) : 849 - 855
  • [42] THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS
    AAPRO, M
    PIGUET, D
    GIGER, K
    BAUER, J
    HAEFLIGER, JM
    BREMER, K
    CALS, L
    CATTAN, A
    CLAVEL, M
    CZYGAN, P
    DEARNALEY, D
    DIEHL, V
    HARJUNG, M
    HARPER, P
    ILLIGER, H
    KAYE, S
    KEIZER, HJ
    KERBRAT, P
    KONIG, HJ
    MONCUQUET, P
    DEBESANCON, C
    NAMER, M
    NOBEL, A
    NORTIER, JWR
    OBERLING, F
    PLAGNE, R
    REICHLE, A
    RIVIERE, A
    SOUKOP, M
    VEENHOF, CHN
    ZYLBERAIT, D
    HUNTER, B
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (09) : 555 - 559
  • [43] SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy
    Jesús García Gómez
    M. Eva Pérez López
    Jesús García Mata
    Dolores Isla Casado
    Clinical and Translational Oncology, 2010, 12 : 770 - 774
  • [44] SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy
    Garcia Gomez, Jesus
    Perez Lopez, M. Eva
    Garcia Mata, Jesus
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11): : 770 - 774
  • [45] ANTIEMETIC EFFICACY OF DEXAMTHEASONE IN COMBINATION FOR OUT-PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY
    ALLAN, SG
    FARQUHAR, DF
    HARRISON, DJ
    LEONARD, RCF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) : 86 - 87
  • [46] COMBINATION METOCLOPRAMIDE AND DEXAMETHASONE - AN EFFECTIVE ANTIEMETIC REGIMEN IN OUTPATIENTS RECEIVING NON-CISPLATIN CHEMOTHERAPY
    STRUM, SB
    MCDERMED, JE
    STRENG, BR
    MCDERMOTT, NM
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (09) : 1057 - 1063
  • [47] Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy
    Longo, F.
    Mansueto, G.
    Lapadula, V.
    Stumbo, L.
    Del Bene, G.
    Adua, D.
    De Filippis, L.
    Bonizzoni, E.
    Quadrini, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (08) : 753 - 757
  • [48] ANTIEMETIC EFFECTS OF GR38032F(SN-307), A NEW 5-HT3 ANTAGONIST, ON CISPLATIN-INDUCED AND CYCLOPHOSPHAMIDE-INDUCED EMESIS IN FERRETS
    ENDO, T
    MONMA, Y
    MINAMI, M
    HAMAUE, N
    TAKANO, Y
    NISHIKIORI, M
    SAITO, H
    TOSHIMITSU, Y
    UEKI, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 1712 - 1712
  • [49] COMPARISON OF THE ANTIEMETIC EFFICACY OF DOMPERIDONE, METOCLOPRAMIDE AND DEXAMETHASONE IN OUT-PATIENTS RECEIVING CHEMOTHERAPY
    CUNNINGHAM, D
    EVANS, C
    POPLE, A
    DEARLING, J
    CHAPPELL, D
    COOMBES, RC
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 226 - 226
  • [50] Effects of antiemetic dexamethasone therapy on bone health in cancer patients receiving systemic chemotherapy
    Hong, A. Ram
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 268 - 268
12345